Spin-off targets new market for stem cells

Guest Contributor
June 24, 2015

A new Montreal biotech company has been launched to commercialize a technology that would overcome the shortage of bone marrow donors for patients with acute myeloid leukemia. Launched by the Institute for Research in Immunology and Cancer - Commercialization of Research and the Centre for Commercialization of Regenerative Medicine, ExCellThera is based on a proprietary technique related to the expansion of stem cells developed by Dr Guy Sauvageau at the Univ of Montreal and Dr Peter Zandstra at the Univ of Toronto. A Phase I and II clinical trial is slated for this year at the Maisonneuve-Rosement Hospital in Montreal....

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.